Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CNTX compared with PALI: revenue, margins and what each company keeps, and the suppliers and customers both name
CNTX
Context Therapeutics Inc.
Change
Mkt cap
Revenue
Revenue
PALI
Palisade Bio, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CNTX
Context Therapeutics Inc.
vs
PALI
Palisade Bio, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
CNTX
No earnings history for CNTX.
PALI
1 of 4 reports
Report
implied
realized
× implied
Q2 FY26
—
▲
+1.90%
—
= implied
CNTX realized, solid
PALI realized, hatched
One scale, both sides: full bar = 2%
× = |realized| ÷ implied
Source: market data
CNTX
Context Therapeutics Inc.
Change
0.20
▲
+6.08%
· post 0.20
Mkt cap
$17.4M
Revenue
—
PALI
Palisade Bio, Inc.
Change
1.11
▼
−4.56%
· post 1.11
Closed
Nov 2 '26
Mkt cap
$202.2M
Revenue
$500,000
Q2 FY26
vs
Compare
Closed
Nov 2 '26
CNTX
Context Therapeutics Inc.
vs
PALI
Palisade Bio, Inc.
0.20
▲
+6.08%
post 0.20
Price
1.11
▼
−4.56%
post 1.11
$17.4M
Mkt cap
$202.2M
—
Revenue
$500,000
Q2 FY26
Change
Change
CNTX
0.20
▲
+6.08%
vs
PALI
1.11
▼
−4.56%
Closed
Nov 2 '26